|1.||Blatt, Lawrence M: 5 articles (03/2008 - 12/2003)|
|2.||Sidwell, Robert W: 4 articles (03/2008 - 06/2005)|
|3.||Wong, Min-Hui: 2 articles (03/2008 - 06/2005)|
|4.||Jung, Kie-Hoon: 2 articles (03/2008 - 06/2005)|
|5.||Gowen, Brian B: 2 articles (03/2008 - 06/2005)|
|6.||Julander, Justin G: 2 articles (04/2007 - 02/2007)|
|7.||Morrey, John D: 2 articles (04/2007 - 02/2007)|
|8.||Zuberi, M: 1 article (01/2011)|
|9.||Seto, R: 1 article (01/2011)|
|10.||Chow, E: 1 article (01/2011)|
|1.||Chronic Hepatitis C
10/01/2000 - "A multicenter, randomized, controlled trial of interferon alfacon-1 compared with alpha-2a-interferon in Chinese patients with chronic hepatitis C virus infection."
12/01/2002 - "In a multicenter, randomized, controlled study, the safety and efficacy of interferon alfacon-1 in comparison with lymphoblastoid interferon-alpha [IFN-alpha (NAMALWA)] was evaluated in patients infected with high-titer chronic hepatitis C virus (HCV). "
01/01/2006 - "[Study of the efficacy of combined therapy with interferon alfacon-1 and ribavirin for chronic hepatitis C]."
01/01/2006 - "The results of combined interferon alfacon-1 and ribavirin therapy of 94 patients with chronic hepatitis C were analyzed. "
06/01/2005 - "Here we present evidence that interferon alfacon-1, a nonnaturally occurring bioengineered alpha interferon approved for the treatment of chronic hepatitis C, is active against Pichinde and Tacaribe arenaviruses in cell culture. "
12/01/2002 - "Collectively, these clinical studies indicate that interferon alfacon-1, as a novel synthetic interferon, may be a useful therapeutic alternative for the effective treatment of hepatitis C."
03/01/2009 - "A patient with hepatitis C developed elevated hepatic transaminase levels despite showing an improvement in viral load after receiving interferon alfacon-1 and ribavirin."
03/01/2009 - "The case of a patient with hepatitis C who developed elevated hepatic transaminase levels associated with the use of interferon alfacon-1 and ribavirin is described. "
06/01/2004 - "[Observation on the efficacy and safety of Infergen combined with capsule ribavirin in treatment of hepatitis C patients]."
04/01/2003 - "A pilot study of the combination of cyclosporin A and interferon alfacon-1 for the treatment of hepatitis C in previous nonresponder patients."
01/01/2011 - "This is a feasibility study of a mobile real-time alerting system to systematically identify potential study subjects for a randomized controlled trial evaluating the safety and efficacy of early intervention with interferon alfacon-1 for patients hospitalized for influenza virus infection. "
06/01/2005 - "In the hamster model of Pichinde virus (PCV) infection, interferon alfacon-1 treatment significantly protected animals from death, prolonged the survival of those that eventually died, reduced virus titers, and limited liver damage characteristic of PCV-induced disease. "
06/01/2005 - "Interferon alfacon-1 protects hamsters from lethal pichinde virus infection."
01/01/2003 - "Viral kinetic data from previously untreated historical control patients with genotype 1 infection who received 9 mcg (n = 12) or 15 mcg (n = 13) of interferon alfacon-1 provided a basis for comparison. "
07/01/1998 - "Data from 704 patients with HCV infection who were randomized to receive consensus IFN-alpha (CIFN) 3 micrograms (n = 232 patients) or 9 micrograms (n = 232 patients), or IFN-alpha 2b 3 million units (MU) (n = 240 patients), were used for these analyses. "
08/01/1986 - "IFN-alpha Con 1 administered at 10(5) to 10(6) U/hamster daily for 9-12 days following tumor challenge was effective in delaying tumor development, as was a natural human IFN-alpha preparation. "
09/01/2008 - "After CaSki cervical cancer cells were induced by rSIFN-co, Infergen, IFNalpha-2b and DDP at the concentration of 0.156 microg/mL, 0.625 microg/mL, 2.500 microg/mL for 72 hours, CaSki cells which had been induced were effected by CTL, the cytotoxicity was determined and calculated by MTT assay. "
|3.||Interferon-alpha (Interferon Alfa)
|4.||Dihydrotachysterol (AT 10)
|7.||Adrenal Cortex Hormones (Corticosteroids)
|10.||Measles-Mumps-Rubella Vaccine (MMR Vaccine)